Merck KGaA, Darmstadt, Germany completes acquisition of Versum Materials


Integration Milestones

February 27, 2019: Formal tender offer

February 27, 2019: Formal tender offer

March 5, 2019: Open Letter to Versum Shareholders from Merck KGaA, Darmstadt, Germany

March 5, 2019: Open Letter to Versum Shareholders from Merck KGaA, Darmstadt, Germany

March 12, 2019: Merck KGaA, Darmstadt, Germany Files Preliminary Proxy Statement

March 12, 2019: Merck KGaA, Darmstadt, Germany Files Preliminary Proxy Statement

March 26, 2019: Merck KGaA, Darmstadt, Germany Commences Tender Offer

March 26, 2019: Merck KGaA, Darmstadt, Germany Commences Tender Offer

April 12, 2019: Definitive Agreement to Acquire Versum Materials

April 12, 2019: Definitive Agreement to Acquire Versum Materials

June 18, 2019: Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

June 18, 2019: Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

September 16, 2019: CFIUS has completed review of the proposed acquisition of Versum

September 16, 2019: CFIUS has completed review of the proposed acquisition of Versum

October 7, 2019: Merck KGaA, Darmstadt, Germany completes acquisition of Versum Materials

October 7, 2019: Merck KGaA, Darmstadt, Germany completes acquisition of Versum Materials

Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. 

Go to Performance Materials' Website

Versum Materials

Versum Materials is accelerating the future of semiconductors by pushing the boundaries of technology. We are an innovation-driven specialty materials company with a deep understanding of chemistry, a long history of customer collaboration and an extensive track record of sustainable solutions for the semiconductor industry.

Whether we are supporting the development of game-changing technology, improving the quality of an existing product or making a manufacturing process more efficient, Versum is making a difference in your future.

Go to Versum Materials' Website

"By acquiring Versum, we will be optimally positioned to capitalize on long-term growth trends in the electronic materials industry. At the same time, we are broadening Performance Materials, balancing our portfolio with three strong business sectors and sharpening our strategic focus on innovation-driven technologies."

Stefan Oschmann

Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement